Jonathan H. Shanks

1.5k total citations
39 papers, 1.1k citations indexed

About

Jonathan H. Shanks is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jonathan H. Shanks has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Jonathan H. Shanks's work include Spectroscopy Techniques in Biomedical and Chemical Research (8 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Urological Disorders and Treatments (7 papers). Jonathan H. Shanks is often cited by papers focused on Spectroscopy Techniques in Biomedical and Chemical Research (8 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Urological Disorders and Treatments (7 papers). Jonathan H. Shanks collaborates with scholars based in United Kingdom, United States and Canada. Jonathan H. Shanks's co-authors include Noel W. Clarke, Peter Gardner, Ehsan Gazi, Kenneth A. Iczkowski, M.D. Brown, Matthew J. Baker, Michael D. Brown, Ashwin Sachdeva, Paul Bassan and David G. Bostwick and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and British Journal of Cancer.

In The Last Decade

Jonathan H. Shanks

38 papers receiving 1.0k citations

Peers

Jonathan H. Shanks
Max Almond United Kingdom
Douglas C. B. Redd United States
Suman Setty United States
Paul Crow United Kingdom
Donal P. Hayes Netherlands
Max Almond United Kingdom
Jonathan H. Shanks
Citations per year, relative to Jonathan H. Shanks Jonathan H. Shanks (= 1×) peers Max Almond

Countries citing papers authored by Jonathan H. Shanks

Since Specialization
Citations

This map shows the geographic impact of Jonathan H. Shanks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan H. Shanks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan H. Shanks more than expected).

Fields of papers citing papers by Jonathan H. Shanks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan H. Shanks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan H. Shanks. The network helps show where Jonathan H. Shanks may publish in the future.

Co-authorship network of co-authors of Jonathan H. Shanks

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan H. Shanks. A scholar is included among the top collaborators of Jonathan H. Shanks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan H. Shanks. Jonathan H. Shanks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sachdeva, Ashwin, Claire A. Hart, Thomas Tawadros, et al.. (2022). Non-canonical EphA2 activation underpins PTEN-mediated metastatic migration and poor clinical outcome in prostate cancer. British Journal of Cancer. 127(7). 1254–1262. 8 indexed citations
2.
Shanks, Jonathan H., et al.. (2020). Human Papilloma Virus (HPV) status may impact treatment outcomes in patients with pre-cancerous penile lesions (an eUROGEN Study). International Journal of Impotence Research. 33(6). 620–626. 12 indexed citations
3.
Shanks, Jonathan H., John R. Srigley, Fadi Brimo, et al.. (2019). Dataset for reporting of carcinoma of the urethra (in urethrectomy specimens): recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 75(4). 453–467. 2 indexed citations
4.
6.
McGuinness, Luke A., Michael S. Floyd, Jonathan H. Shanks, et al.. (2014). Epithelioid haemangioma: a rare cause of painful erections and sleep deprivation. International Urology and Nephrology. 46(9). 1747–1750. 2 indexed citations
7.
Bassan, Paul, Ashwin Sachdeva, Jonathan H. Shanks, et al.. (2013). Whole organ cross-section chemical imaging using label-free mega-mosaic FTIR microscopy. The Analyst. 138(23). 7066–7066. 24 indexed citations
8.
Hughes, C., Michael D. Brown, Jonathan H. Shanks, et al.. (2012). FTIR microspectroscopy of selected rare diverse sub‐variants of carcinoma of the urinary bladder. Journal of Biophotonics. 6(1). 73–87. 39 indexed citations
9.
Plumb, Andrew, Jonathan H. Shanks, & Rohit Kochhar. (2010). Development of aggressive angiomyxoma like tumour in a renal transplant. Clinical Radiology. 65(5). 423–426. 5 indexed citations
10.
Shanks, Jonathan H., et al.. (2010). High-dose Interleukin-2 Can Produce a High Rate of Response and Durable Remissions in Appropriately Selected Patients With Metastatic Renal Cancer. Journal of Immunotherapy. 34(1). 107–112. 24 indexed citations
11.
Shanks, Jonathan H. & Kenneth A. Iczkowski. (2009). Spindle cell lesions of the bladder and urinary tract. Histopathology. 55(5). 491–504. 11 indexed citations
12.
Baker, Matthew J., Ehsan Gazi, M.D. Brown, et al.. (2008). FTIR-based spectroscopic analysis in the identification of clinically aggressive prostate cancer. British Journal of Cancer. 99(11). 1859–1866. 168 indexed citations
13.
Gazi, Ehsan, John Dwyer, Nicholas P. Lockyer, et al.. (2003). The combined application of FTIR microspectroscopy and ToF-SIMS imaging in the study of prostate cancer. Faraday Discussions. 126. 41–41. 73 indexed citations
14.
Menasce, Lia P., Jonathan H. Shanks, S S Banerjee, & Martin Harris. (2001). Follicular lymphoid hyperplasia of the hard palate and oral mucosa: report of three cases and a review of the literature. Histopathology. 39(4). 353–358. 23 indexed citations
15.
Iczkowski, Kenneth A., Jonathan H. Shanks, Virgil Gadaleanu, et al.. (2001). Inflammatory Pseudotumor and Sarcoma of Urinary Bladder: Differential Diagnosis and Outcome in Thirty-Eight Spindle Cell Neoplasms. Modern Pathology. 14(10). 1043–1051. 93 indexed citations
16.
Savage, J. M., et al.. (1999). Improved prognosis for congenital nephrotic syndrome of the Finnish type in Irish families. Archives of Disease in Childhood. 80(5). 466–469. 14 indexed citations
18.
Skailes, G., Lia P. Menasce, Shiladitya Banerjee, Jonathan H. Shanks, & Jennifer Logue. (1998). Adenocarcinoma of the rete testis. Clinical Oncology. 10(6). 401–403. 7 indexed citations
19.
McCluggage, W. Glenn, Jonathan H. Shanks, Ken Arthur, & S S Banerjee. (1998). Cellular proliferation and nuclear ploidy assessments augment established prognostic factors in predicting malignancy in testicular Leydig cell tumours. Histopathology. 33(4). 361–368. 33 indexed citations
20.
Shanks, Jonathan H., et al.. (1997). Dissecting aneurysm of the pulmonary artery associated with a large facial cavernous haemangioma. Histopathology. 30(4). 390–392. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026